B
Beijing SL Pharmaceutical Co Ltd
SZSE:002038
Beijing SL Pharmaceutical Co Ltd
SZSE:002038
Price:
8.47 CNY
0.24%
Market Closed
Updated:
May 19, 2024
Beijing SL Pharmaceutical Co Ltd
Operating Expenses
|
Beijing SL Pharmaceutical Co Ltd
Operating Expenses Peer Comparison
Comparables:
6160
1801
603392
300122
300896
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
B
|
Beijing SL Pharmaceutical Co Ltd
SZSE:002038
|
Operating Expenses
-¥528.7m
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-12%
|
|
|
Beigene Ltd
HKEX:6160
|
Operating Expenses
-¥23.5B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Operating Expenses
-¥6.5B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Operating Expenses
-¥3.1B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Operating Expenses
-¥4.8B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-30%
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Operating Expenses
-¥458.8m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
See Also
What is Beijing SL Pharmaceutical Co Ltd's Operating Expenses?
Operating Expenses
-528.7m
CNY
-528.7m
CNY
Based on the financial report for Mar 31, 2024, Beijing SL Pharmaceutical Co Ltd's Operating Expenses amounts to -528.7m CNY.
What is Beijing SL Pharmaceutical Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-12%
-12%
Over the last year, the Operating Expenses growth was 28%. The average annual Operating Expenses growth rates for Beijing SL Pharmaceutical Co Ltd have been 13% over the past three years , 13% over the past five years , and -12% over the past ten years .
You don't have any saved screeners yet
